MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PRIME BRPL 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
|
Back to Search Results |
|
Model Number APB-1-2-3D-ES |
Device Problems
Therapy Delivered to Incorrect Body Area (1508); Separation Failure (2547)
|
Patient Problem
Foreign Body In Patient (2687)
|
Event Date 07/09/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information regarding an axium coil that had non-detachment and not implanted at the intended location.The patient was undergoing a stent + coil embolization procedure to treat a ruptured saccular left internal carotid artery (ica) c4 cavernous sinus aneurysm.The aneurysm max diameter was 4.7mm and the neck diameter was 4.5mm.Blood flow and vessel tortuosity were normal.It was reported that the axium coil and all accessory devices were prepared per the instructions for use (ifu).During the treatment of the aneurysm, the stent was half-deployed.The coil was filled and successfully formed a hoop.The axium coil (model: apb-1-2-3d-es was then used to fill.Manual detachment with the hypotube was performed and the delivery wire was successfully pulled out.However, when the pusher rod was retracted, the coil was pulled out of the aneurysm and it was noted the coil was still attached to the pusher.After repeated adjustments and rotation of the pusher, the coil finally detached.However, at that point, a portion of the coil was outside the aneurysm.The stent was then fully deployed and secured the coil to the vessel wall and the surgery was completed.There were no associated patient symptoms or other complications associated with the event.Ancillary devices: 8f gilding guide catheter, echelon 10 microcatheter, synchro 14 guidewire.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received reported that prior to coil non-detachment, there were no issues encountered.No pushwire¿damage obs erved after removal from the patient.Aspirin and clopidogrel routine double antibody in perioperative period was noted.
|
|
Search Alerts/Recalls
|
|
|